Wildfire Smoke Exposure and Incident Dementia.

Autor: Elser H; Department of Neurology, University of Pennsylvania, Philadelphia.; Editorial Fellow, JAMA Neurology., Frankland TB; Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, Hawaii., Chen C; Scripps Institution of Oceanography, University of California, San Diego., Tartof SY; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California., Mayeda ER; Department of Epidemiology, UCLA Fielding School of Public Health, University of California, Los Angeles., Lee GS; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California., Northrop AJ; Vagelos College of Physicians and Surgeons, Columbia University, New York, New York., Torres JM; Department of Epidemiology & Biostatistics, University of California, San Francisco., Benmarhnia T; Scripps Institution of Oceanography, University of California, San Diego.; Irset Institut de Recherche en Santé, Environnement et Travail, UMR-S 1085, Inserm, University of Rennes, EHESP, Rennes, France., Casey JA; Department of Environmental and Occupational Health Sciences, University of Washington School of Public Health, Seattle.; Department of Epidemiology, University of Washington School of Public Health, Seattle.

Publikováno v: JAMA neurology [JAMA Neurol] 2024 Nov 25. Date of Electronic Publication: 2024 Nov 25.

Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 Sublineages.

Autor: Tartof SY; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Slezak JM; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Puzniak L; Global Vaccines and Antivirals, Pfizer Inc, Collegeville, Pennsylvania, USA., Frankland TB; Center for Integrated Health Care Research (CIHR), Kaiser Permanente Hawaii, Honolulu, Hawaii, USA., Ackerson BK; Department of Pediatric Infectious Diseases, Southern California Permanente Medical Group, Harbor City, California, USA., Jodar L; Global Vaccines and Antivirals, Pfizer Inc, Collegeville, Pennsylvania, USA., McLaughlin JM; Global Vaccines and Antivirals, Pfizer Inc, Collegeville, Pennsylvania, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2024 Jul 01; Vol. 11 (7), pp. ofae370. Date of Electronic Publication: 2024 Jul 01 (Print Publication: 2024).

Predictors of nirmatrelvir-ritonavir receipt among COVID-19 patients in a large US health system.

Autor: Malden DE; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA. Debbie.E.Malden@kp.org., McLaughlin JM; Pfizer Inc, New York, USA., Hong V; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Lewnard J; Division of Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, CA, 94720, USA.; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, 94720, USA.; Center for Computational Biology, College of Engineering, University of California, Berkeley, Berkeley, CA, 94720, USA., Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Puzniak L; Pfizer Inc, New York, USA., Kim JS; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Takhar H; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Frankland TB; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Slezak JM; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA., Tartof SY; Department of Research and Evaluation, Kaiser Permanente Southern California, 100 South Los Robles, Pasadena, CA, 91101, USA. Sara.Y.Tartof@kp.org.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, 91101, USA. Sara.Y.Tartof@kp.org.

Publikováno v: Scientific reports [Sci Rep] 2024 Mar 29; Vol. 14 (1), pp. 7485. Date of Electronic Publication: 2024 Mar 29.

Effectiveness of BNT162b2 BA.4/5 bivalent mRNA vaccine against a range of COVID-19 outcomes in a large health system in the USA: a test-negative case-control study.

Autor: Tartof SY; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA; Department of Health Systems Science, Kaiser Permanente Bernard J Tyson School of Medicine, Pasadena, CA USA. Electronic address: sara.y.tartof@kp.org., Slezak JM; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Puzniak L; Pfizer, Collegeville, PA, USA., Hong V; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Frankland TB; Kaiser Permanente Hawaii Center for Integrated Health Care Research, Honolulu, HI, Hawaii., Ackerson BK; Southern California Permanente Medical Group, Harbor City, CA, USA., Xie F; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Takhar H; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Ogun OA; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Simmons S; Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Zamparo JM; Pfizer, Collegeville, PA, USA., Valluri SR; Pfizer, Collegeville, PA, USA., Jodar L; Pfizer, Collegeville, PA, USA., McLaughlin JM; Pfizer, Collegeville, PA, USA.

Publikováno v: The Lancet. Respiratory medicine [Lancet Respir Med] 2023 Dec; Vol. 11 (12), pp. 1089-1100. Date of Electronic Publication: 2023 Oct 25.

Development of an Electronic Health Record-Based Algorithm for Predicting Lung Cancer Screening Eligibility in the Population-Based Research to Optimize the Screening Process Lung Research Consortium.

Autor: Burnett-Hartman AN; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO., Powers JD; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO., Hixon BP; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO., Carroll NM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO., Frankland TB; Center for Integrated Healthcare Research, Kaiser Permanente Hawaii, Oahu, HI., Honda SA; Center for Integrated Healthcare Research, Kaiser Permanente Hawaii, Oahu, HI.; Hawaii Permanente Medical Group, Oahu, HI., Saia C; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Rendle KA; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Greenlee RT; Marshfield Clinic Research Institute, Marshfield, WI., Neslund-Dudas C; Henry Ford Health and Henry Ford Cancer Institute, Detroit, MI., Zheng Y; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA., Vachani A; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Ritzwoller DP; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300063.